SFX by Ex Libris Inc.

Title:	Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization
Source:	Genomics [0888-7543] Wijmenga, Cisca yr:1991

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wijmenga, C. "Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy." Nature genetics 2.1 (1992): 26-30.
description	2.	Tupler, R. "Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1." Nature 439.7079 (2006): 973-7.
description	3.	Vilquin, J-T J. "Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients." Gene therapy 12.22 (2005): 1651-1662.
description	4.	Okano, M. "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development." Cell 99.3 (1999): 247-57.
description	5.	Gabellini, D. "Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle." Cell 110.3: 339-348.
description	6.	Lemmers, George W J. "Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere." Nature genetics 32.2: 235-236.
description	7.	Andrews, P W W. "A comparative study of eight cell lines derived from human testicular teratocarcinoma." International journal of cancer 26.3 (1980): 269-280.
description	8.	Miyabayashi, M. "Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency." Proceedings of the National Academy of Sciences of the United States of America 104.13 (2007): 5668-73.
description	9.	Alter, J. "Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology." Nature medicine 12.2 (2006): 175-7.
description	10.	Rothstein, Jeffrey D D. "Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression." Nature 433.7021 (2004): 73-7.
description	11.	Wijmenga, C. "Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions." Genomics 19.1 (1993): 21-6.
description	12.	Cossu, O. "Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs." Nature 444.7119 (2007): 574-9.
description	13.	Kaneda, M. "Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting." Nature 429.6994 (2004): 900-903.
description	14.	Winokur, Sara T T. "Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress." Neuromuscular disorders 13.4 (2003): 322-33.
description	15.	Lefkowitz, S S L. "Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem." Medical hypotheses 65.4 (2005): 716-21.
description	16.	Li, E. "Chromatin modification and epigenetic reprogramming in mammalian development." Nature reviews. Genetics 3.9 (2002): 662-73.
description	17.	Xie, S. "Cloning, expression and chromosome locations of the human DNMT3 gene family." Gene 236.1 (1999): 87-95.
description	18.	Li, E. "Targeted mutation of the DNA methyltransferase gene results in embryonic lethality." Cell 69.6 (1992): 915-26.
description	19.	Reik, J. "Epigenetic reprogramming in mammalian development." Science 293.5532: 1089-1093.
description	20.	Spitali, P. "Splice Modulating Therapies for Human Disease." Cell 148.6 (2012): 1085-1088.